You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

126 Results
Guidelines and Advice
Jan 2020
Guidelines and Advice
Status: Current
ID: GL #4-4v2
Version: 2
Sep 2020
Statistical Reports
Guidelines and Advice
Status: Current
ID: GL-C50-32
Jan 2021
Drug
Other Name(s): Vepesid®
Jul 2020
Drug
Jul 2020
Drug
Jan 2021
Drug
Other Name(s): Zinecard®
Dec 2020
Drug
Other Name(s): Procytox®
Oct 2020
Regimen
Cancer Type:
Sarcoma, 
Soft Tissue, 
Skin, 
Melanoma
Intent: Palliative
Aug 2020

Pages